In this issue
Human Vaccines & Immunotherapeutics
Volume 8, Issue 2February 2012
View current issue
About the cover
Influenza virus vaccine production in action: Vero cells on microcarriers are sloughing off the microcarriers as the virus are produced 12 hours...Continue reading
Most Popular Downloads
Clement Lewin
Merle M. Böhmer, Dietmar Walter, Gérard Krause, et al.
Important Journal Links
Landes Highlights
Articles of interest recently published in our other journals
Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases. Carmen Fehr, K. Dominik Conrad and Michael Niepmann. Cell Cycle 11(2). January 15, 2012.
Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine. Candida Fasano and Darja Kanduc. Self/Nonself 2(2); April/May/June 2011. Review.
Recombinant adeno-associated virus expressing a modified transcription factor triggered by the hepatitis C viral protease NS3/4a. Chul Hyun Joo. Bioengineered Bugs 2(3); May/June 2011.
Human Vaccines has been renamed Human Vaccines & Immunotherapeutics!
Vaccine research and development has been extending its traditional reach beyond the prevention of bacterial or viral diseases. Besides therapeutic vaccines for viral diseases, there are also applications outside of infectious diseases for vaccines and immunotherapeutics based on antibodies, other proteins or nucleic acids – these approaches are targeted to diseases in diverse fields including cancer, autoimmunity, inflammation, allergy, Alzheimer’s and addiction. Many of these new vaccines and immunotherapeutics should become available within the next decade, with consequent benefit for human health.
In recognition of this extension in the scope of our field, our journal would like to attract more manuscripts in the areas of immunotherapeutics and non-ID vaccines while maintaining our focus in more traditional vaccines. Thus, we are renaming the journal Human Vaccines & Immunotherapeutics (HV&I).
For more information see the Editorial in the October issue!
Editor-in-Chief
Ronald W. Ellis
Senior Vice President R&D and Chief Technology Officer
NasVax Ltd., Ness Ziona, Israel
Medline/PubMed, PubMed Central, Science Citation Index Expanded (available as the ISI Web of Science, ISI Alerting Services, Biosis Previews and Biological Abstracts).
Find us on Facebook
Submit your paper to Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics (HV&I) utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.
Click here to submit your manuscript to HV&I.
HV&I is indexed in Medline/PubMed and in the Science Citation Index Expanded.
Upcoming Meetings
2nd Annual Global Vaccine Forum
Mar 1- 2, 2012
Vienna, Austria
19th Conference on Retroviruses and Opportunistic Infections
Mar 5-8, 2012
Seattle, Washington
International Conference on Emerging Infectious Diseases (ICEID 2012)
Mar 11-14, 2012
Atlanta, Georgia
8th International Symposium on Pneumococci and Pneumococcal Disease
Mar 11-15, 2012
Iguaçu Falls, Brazil
HIV Vaccines
Part of the Keystone Symposia Global Health Series
March 21 - 26, 2012
Keystone, Colorado
5th Diabetes Drug Discovery & Development
April 19 - 20, 2012
Boston, MA
Vaccines China 2012
April 23- 26, 2012
Shanghai, China
AVID 2012
4th Australasian Vaccines and Immunotherapeutics Development
May 2-4, 2012
Brisbane, QLD, Australia
Immunology 2012: The American Association of Immunologists Annual Meeting
May 4-8, 2012
Boston, Massachusetts
National Foundation for Infectious Diseases Annual Conference on Vaccine Research
May 7-12, 2012
Baltimore, Maryland
Phacilitate Immunotherapy Forum
May 9-11, 2012
Barcelona, Spain
8th Annual BioMalPar|EVIMalaR Conference Biology and Pathology of the Malaria Parasite
May 14-16, 2012
Heidelberg, Germany
World Congress on Vaccines, Immunization and Immunotherapy
June 5-7, 2012
Barcelona, Spain
Symposia Human Immunity
August 19 - 21, 2012
Lisbon, Portugal
